Collaborations In Chemisty is the chemical division of Collaborations In Communications.

INFO: We provide our expertise as consultants to pharmaceutical and biotechnology companies to assist you in your drug discovery projects by applying an array of commercial computational technologies to improve success.

We can assist start-up and other companies in the discovery, development and commercialization of novel technologies for drug discovery.

We can apply our expert opinion to the preparation of your SBIR grants on topics ranging from drug metabolism, toxicology, systems biology and other areas of preclinical pharmaceutical research and development.

We can provide editorial assistance in the preparation of high quality scientific publications and marketing materials.

We can also organize scientific meetings.

Sean Ekins Ph.D, D.Sc

email at
ekins@collaborations.com

Sean Ekins graduated from the University of Aberdeen; receiving his M.Sc., Ph.D. and D.Sc. His areas of interest are in vitro and computational ADME/Tox, biomarkers, systems biology and computational drug discovery. He was a postdoctoral fellow at Lilly Research Laboratories in the drug disposition group. He has worked as a senior scientist at Pfizer and Lilly Research Laboratories in drug-drug interaction screening and computational ADME/Tox groups, respectively and as Associate Director of Computational Drug Discovery at Concurrent Pharmaceuticals, Inc. and Vice President of Computational Biology at GeneGo.
He is Adjunct Associate Professor, School of Pharmacy Department of Pharmaceutical Sciences, University of Maryland; Adjunct Professor in the Department of Pharmacology at University of Medicine and Dentistry of New Jersey - Robert Wood Johnson Medical School, Piscataway, NJ; Senior Vice President of Computational Biology at Arnold Consultancy and Technology LLC; Principal Consultant for Collaborations in Chemistry and Collaborations Director at collaborative Drug Discovery Inc..
He has authored or co-authored ~150 peer reviewed papers and book chapters as well as edited three books. He is Associate Editor of the Journal of Pharmacological and Toxicological Methods, on the Editorial Board of Drug Metabolism and Disposition, Drug Discovery Today, Mutation Research Reviews and the ChemSpider Journal of Chemistry as well as the Reviews Editor for Pharmaceutical Research. He currently serves on the scientific advisory board for Emiliem Inc http://www.emiliem.com/. ChemSpider, Assay Depot and the advisory board for Chemical Informatics at Indiana University
Sean has published 3 books for Wiley "Computer applications in pharmaceutical research and development" http://www.wiley.com/WileyCDA/WileyTitle/productCd-0471737798.html, "Computational Toxicology: Risk Assessment For Pharmaceutical and Environmental Chemicals" http://www.wiley.com/WileyCDA/WileyTitle/productCd-0470049626.html, and with Xu JJ, "Drug Efficacy, Safety, and Biologics Discovery: Emerging Technologies and Tools" http://www.wiley.com/WileyCDA/WileyTitle/productCd-0470225556.html
He is currently editing a book series "Technologies for the Pharmaceutical Industry".
His research profile can be found at Community of Science http://myprofile.cos.com/ekinssean .